BioXell SpA (BXLN.S)
BXLN.S on Swiss Exchange
7.40CHF
18 Dec 2009
7.40CHF
18 Dec 2009
Price Change (% chg)
CHF0.34 (+4.82%)
CHF0.34 (+4.82%)
Prev Close
CHF7.06
CHF7.06
Open
CHF7.17
CHF7.17
Day's High
CHF7.42
CHF7.42
Day's Low
CHF7.16
CHF7.16
Volume
41,814
41,814
Avg. Vol
10,012
10,012
52-wk High
CHF7.73
CHF7.73
52-wk Low
CHF2.50
CHF2.50
BXLN.S
About
BioXell SpA is an Italy-based biopharmaceutical company. The Company focuses on the research, development and commercialization of therapies for various medical needs. It is active in a range of therapeutic areas, such as urology (benign prostatic hyperplasia, overactive bladder and male infertility), inflammation (sepsis,... (more)
Overall
| Beta: | 1.74 |
| Market Cap (Mil.): | CHF37.99 |
| Shares Outstanding (Mil.): | 5.38 |
| Annual Dividend: | -- |
| Yield (%): | -- |
Financials
| BXLN.S | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 6.57 | 4.61 |
| EPS (TTM): | -8.06 | -- | -- |
| ROI: | -32.87 | 6.19 | 2.83 |
| ROE: | -35.23 | 9.19 | 3.59 |
Earnings vs 
Estimates
© Copyright 2009 Thomson Reuters
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
